Both in Pharmaceuticals
Benitec Biopharma vs Emergent Biosolutions
Over the past year BNTC returned −44.7% and EBS returned −31.2%; their daily moves had a correlation of 0.18.
BNTC −44.7% EBS −31.2%Growth of $1, one year, split-adjusted
| Metric | BNTC | EBS |
|---|---|---|
| Price | $8.68 | $6.67 |
| Market cap | $302.8M | $342.0M |
| Today | +1.05% | +5.21% |
| 1 month | −13.4% | −2.8% |
| 6 months | −28.7% | −19.0% |
| Year to date | −35.6% | −46.0% |
| 1 year | −47.5% | −31.5% |
| Revenue growth (YoY) | — | +66.3% |
| Gross margin | — | 58.6% |
| Net margin | — | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $180.0M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 97.2% |
| Short % of float | 9.4% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).